The estimated Net Worth of Pamela Haley is at least $255 Thousand dollars as of 1 August 2022. Ms Haley owns over 700 units of Arcadia Biosciences Inc stock worth over $14,552 and over the last 5 years she sold RKDA stock worth over $0. In addition, she makes $240,000 as CFO & Corp. Sec. at Arcadia Biosciences Inc.
Ms has made over 3 trades of the Arcadia Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she bought 700 units of RKDA stock worth $490 on 1 August 2022.
The largest trade she's ever made was buying 700 units of Arcadia Biosciences Inc stock on 1 August 2022 worth over $490. On average, Ms trades about 420 units every 182 days since 2020. As of 1 August 2022 she still owns at least 5,088 units of Arcadia Biosciences Inc stock.
You can see the complete history of Ms Haley stock trades at the bottom of the page.
Pamela Haley is the CFO & Corp. Sec. at Arcadia Biosciences Inc.
As the CFO & Corp. Sec. of Arcadia Biosciences Inc, the total compensation of Ms Haley at Arcadia Biosciences Inc is $240,000. There are no executives at Arcadia Biosciences Inc getting paid more.
Ms Haley is 49, she's been the CFO & Corp. Sec. of Arcadia Biosciences Inc since . There are 8 older and 2 younger executives at Arcadia Biosciences Inc. The oldest executive at Arcadia Biosciences Inc is Donald Emlay, 73, who is the Vice President - Regulatory Affairs and Compliance.
Pamela's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS, CA, 95618.
Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp, and Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.
arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.
Arcadia Biosciences Inc executives and other stock owners filed with the SEC include: